• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE II LVAS IMPLANT KIT (WITH SEALED GRAFTS); VENTRICULAR (ASSIST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE II LVAS IMPLANT KIT (WITH SEALED GRAFTS); VENTRICULAR (ASSIST) BYPASS Back to Search Results
Model Number 106015
Device Problems Mechanical Problem (1384); Decreased Pump Speed (1500); Pumping Stopped (1503)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/07/2024
Event Type  malfunction  
Manufacturer Narrative
Historically related mfr 2916596-2019-03994 covering the full-length driveline replacement in the past; 2916596-2020-03532 covering short to shield.No further information was provided.A supplemental report will be submitted once the manufacturer¿s investigation is complete.
 
Event Description
It was reported that the patient was seen in clinic with pump stop alarms, low speed advisories, and low flow alarms.Event log files were submitted for review.The event log confirmed that pump speed dropped below the low-speed limit and captured pump stops on 07mar2024 and 08mar2024.These events occurred on battery power and appeared to be caused by a phase to phase short.It was noted that the patient had a full-length driveline replacement previously, so another driveline repair was not possible.
 
Event Description
It was additionally reported that the patient was unaware of the alarms.The patient had no further alarms.The patient was admitted as a status 2 candidate for a heart transplant.
 
Manufacturer Narrative
Manufacturer's investigation conclusion: review of the account¿s submitted log files confirmed the reported low speed alarms and pump stop events; however, a specific cause for the events could not be conclusively determined as no product was returned for evaluation.The submitted log file contained events from (b)(6) 2024 through (b)(6) 2024.A low speed and pump stop event was captured on (b)(6) 2024 which was accompanied by elevations in pump power and estimated flow, as well as a decrease in pulsatility index (pi).Based on previous complaint experience, this type of behavior captured within the submitted log file is potentially indicative of a foreign material, such as thrombus, coming in contact with the spinning rotor and creating drag.Additional pump stops were captured on (b)(6) 2024 and (b)(6) 2024 while the patient was connected to battery power; however, a specific cause for the events could not be conclusively determined.No other notable events or alarms were captured.The patient remains ongoing on heartmate (hm) ii left ventricular assist system (lvas), serial number (b)(6).No further related events have been reported at this time.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The heartmate (hm) ii left ventricular assist system (lvas) instructions for use (ifu) rev.C and the heartmate ii patient handbook rev.C are currently available.Section 1 of the ifu, ¿introduction¿, lists potential adverse events, including device thrombosis, that may be associated with the use of the heartmate ii lvas.Section 1 also addresses pump parameters including pump speed, power, flow, and pulsatility index (pi).In reference to power, this section explains that pump power is a direct measurement of motor voltage and current; therefore, changes in pump speed, flow, or physiological demand can affect pump power.Gradual increases in power may signal thrombus in the pump and depending on the speed of the pump, power values greater than 10 to 12 watts also can indicate the presence of a thrombus.Additionally, lower pi values indicate less ventricular filling and lower pulsatility (ie, the pump is providing greater support and further unloading the ventricle).Under otherwise stable conditions, a significant drop in pi value may indicate a decrease in circulating blood volume.Section 6 of the ifu "patient care and management" outlines the recommended anticoagulation therapy and international normalized ratio (inr) range.This section also outlines indications of pump thrombosis, as well as how to respond to such events.Section 7 of the ifu and section 5 of the patient handbook address all system controller alarms, as well as the appropriate actions associated with them.Furthermore, these documents provide information regarding events that may cause the pump to stop and how to prevent pump stops from occurring.No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE II LVAS IMPLANT KIT (WITH SEALED GRAFTS)
Type of Device
VENTRICULAR (ASSIST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer (Section G)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer Contact
lindsey sallese
6035 stoneridge drive
pleasanton, CA 94588
7818528207
MDR Report Key18986067
MDR Text Key338699296
Report Number2916596-2024-01800
Device Sequence Number1
Product Code DSQ
UDI-Device Identifier00813024011224
UDI-Public00813024011224
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P060040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Nurse Practitioner
Type of Report Initial,Followup
Report Date 05/15/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date05/31/2019
Device Model Number106015
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 03/19/2024
Initial Date FDA Received03/27/2024
Supplement Dates Manufacturer Received05/06/2024
Supplement Dates FDA Received05/15/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/05/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age46 YR
Patient SexMale
Patient Weight108 KG
-
-